Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

@article{Bassiouny2013UseOD,
  title={Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.},
  author={Mohamed Bassiouny and Walid S Saliba and John Jack Rickard and Mingyuan Shao and Albert Sey and Mariam Diab and David O'B. Martin and Ayman Hussein and Maurice Khoury and Bernard S Abi-Saleh and Samir Alam and Jay Sengupta and P. Peter Borek and Bryan J Baranowski and Mark J Niebauer and Thomas D Callahan and N. Somasekhar Varma and Mina K. Chung and Patrick Tchou and Mohamed H Kanj and Thomas J. Dresing and Bruce D. Lindsay and Oussama Musbah Wazni},
  journal={Circulation. Arrhythmia and electrophysiology},
  year={2013},
  volume={6 3},
  pages={460-6}
}
BACKGROUND Pulmonary vein isolation (PVI) for atrial fibrillation is associated with a transient increased risk of thromboembolic and hemorrhagic events. We hypothesized that dabigatran can be safely used as an alternative to continuous warfarin for the periprocedural anticoagulation in PVI. METHODS AND RESULTS A total of 999 consecutive patients undergoing PVI were included; 376 patients were on dabigatran (150 mg), and 623 patients were on warfarin with therapeutic international normalized… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 67 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…